Article
High resolution copy number inference in cancer using short-molecule nanopore sequencing
2020-12-29
Abstract excerpt
<h4>ABSTRACT</h4> Genome copy number is an important source of genetic variation in health and disease. In cancer, clinically actionable Copy Number Alterations (CNAs) can be inferred from short-read sequencing data, enabling genomics-based precision oncology. Emerging Nanopore sequencing technologies offer the potential for broader clinical utility, for example in smaller hospitals, due to lower instrument cost,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b674b09f-7070-50f8-b806-1b594b6aec47
- DOI
- 10.1101/2020.12.28.424602
